<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="77343">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02052245</url>
  </required_header>
  <id_info>
    <org_study_id>11.39.NRC</org_study_id>
    <nct_id>NCT02052245</nct_id>
  </id_info>
  <brief_title>Pre/Term Milk Profiling</brief_title>
  <official_title>Longitudinal Composition of Human Milk for Term and Preterm Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <authority>Switzerland: Ethikkommission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims for an in-depth characterization of human milk of mothers who delivered
      prematurely to decipher differences with milk of mothers who delivered at the expected term,
      with a particular focus on milk proteins
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Quantification of total protein concentration in human milk</measure>
    <time_frame>from delivery, up to 4 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quantification of total lipids and carbohydrates</measure>
    <time_frame>From delivery, up to 4 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determination of Calcium and Phosphorous content</measure>
    <time_frame>From delivery, up to 4 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determination of peptide profiles and content</measure>
    <time_frame>From delivery, up to 4 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determination of miRNA content</measure>
    <time_frame>From delivery, up to 4 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Preterm Milk</condition>
  <condition>Term Milk</condition>
  <arm_group>
    <arm_group_label>Subject delivering preterm baby</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Subject delivering term baby</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Mothers who will breast feed their baby
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Having obtained informed consent

          -  Group 1 (term delivery): Gestational age between 37 0/7 and not above 41   6/7 weeks

          -  Group 2 (preterm delivery): Gestational age between 28 0/7 and 32 6/7 weeks

          -  Age: Mother ≥ 18 years old

          -  Partial or total breast feeding

          -  Having a freezer compartment at home (approx. -18°C)

          -  Good understanding of the French language

        Exclusion Criteria:

          -  Suffering from diabetes (type I or II) before pregnancy

          -  Alcohol consumption: more than 1 standard drink / day

          -  Drug addicted

          -  Subject who cannot be expected to comply with the study procedures.

          -  Currently participating in an interventional therapeutic clinical trial
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean-Francois Tolsa, Professor</last_name>
    <email>Jean-francois.Tolsa@chuv.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinic of neonatology - Avenue Pierre Decker 2</name>
      <address>
        <city>Lausanne</city>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Francois Tolsa, Professor</last_name>
      <email>Jean-Francois.Tolsa@chuv.ch</email>
    </contact>
    <investigator>
      <last_name>Jean-Francois Tolsa, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 30, 2014</lastchanged_date>
  <firstreceived_date>October 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
